Trial Profile
Association of Azithromycin 1,5%/Loteprednol 0,5% Eye Drops Versus Individual Administration of Azithromycin 1,5% and Loteprednol 0,5% in the Treatment of Ocular Inflammation and Infection
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2014
Price :
$35
*
At a glance
- Drugs Azithromycin/loteprednol-etabonate (Primary) ; Azithromycin; Loteprednol etabonate
- Indications Bacterial infections; Blepharitis; Conjunctivitis; Keratitis; Ophthalmic infections
- Focus Registrational; Therapeutic Use
- Sponsors Adapt Produtos Oftalmologicos
- 10 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 10 Dec 2012 New trial record